Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Trembleau

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Biochemical Society Transactions|May 1, 1997
Immune deviation towards Th2 inhibits Th-1-mediated autoimmune diabetesL Adorini, S Trembleau
Springer Seminars in Immunopathology|January 1, 1992
Approaches toward peptide-based immunotherapy of autoimmune diseasesL Adorini, J C Guéry, S Trembleau
Autoimmunity|January 1, 1996
Manipulation of the Th1/Th2 cell balance: an approach to treat human autoimmune diseases?L Adorini, J C Guéry, S Trembleau
Advances in Pharmacology (San Diego, Calif.)|January 1, 1995
Advances in selective immunosuppressionL Adorini, J C Guéry, S Trembleau
Annals of the New York Academy of Sciences|October 31, 1996
The role of IL-12 in the pathogenesis of Th1 cell-mediated autoimmune diseasesL Adorini, S Gregori, J Magram, et al.
Immunology Today|August 1, 1995
The role of IL-12 in the induction of organ-specific autoimmune diseasesS Trembleau, T Germann, M K Gately, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1992
Absence of T cell tolerance to pancreatic islet cellsS S Burtles, S Trembleau, K Drexler, et al.
Trends in Pharmacological Sciences|May 1, 1993
Selective immunosuppressionL Adorini, J C Guéry, G Rodriguez-Tarduchy, et al.
Immunology Today|June 1, 1993
Selective immunosuppressionL Adorini, J C Guéry, G Rodriguez-Tarduchy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 21, 2001
IL-12 administration reveals diabetogenic T cells in genetically resistant I-Ealpha-transgenic nonobese diabetic mice: resistance to autoimmune diabetes is associated with binding of Ealpha-derived peptides to the I-A(g7) moleculeS Trembleau, S Gregori, G Penna, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Biochemical Society Transactions|May 1, 1997
Immune deviation towards Th2 inhibits Th-1-mediated autoimmune diabetesL Adorini, S Trembleau
Springer Seminars in Immunopathology|January 1, 1992
Approaches toward peptide-based immunotherapy of autoimmune diseasesL Adorini, J C Guéry, S Trembleau
Autoimmunity|January 1, 1996
Manipulation of the Th1/Th2 cell balance: an approach to treat human autoimmune diseases?L Adorini, J C Guéry, S Trembleau
Advances in Pharmacology (San Diego, Calif.)|January 1, 1995
Advances in selective immunosuppressionL Adorini, J C Guéry, S Trembleau
Annals of the New York Academy of Sciences|October 31, 1996
The role of IL-12 in the pathogenesis of Th1 cell-mediated autoimmune diseasesL Adorini, S Gregori, J Magram, et al.
Immunology Today|August 1, 1995
The role of IL-12 in the induction of organ-specific autoimmune diseasesS Trembleau, T Germann, M K Gately, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1992
Absence of T cell tolerance to pancreatic islet cellsS S Burtles, S Trembleau, K Drexler, et al.
Trends in Pharmacological Sciences|May 1, 1993
Selective immunosuppressionL Adorini, J C Guéry, G Rodriguez-Tarduchy, et al.
Immunology Today|June 1, 1993
Selective immunosuppressionL Adorini, J C Guéry, G Rodriguez-Tarduchy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 21, 2001
IL-12 administration reveals diabetogenic T cells in genetically resistant I-Ealpha-transgenic nonobese diabetic mice: resistance to autoimmune diabetes is associated with binding of Ealpha-derived peptides to the I-A(g7) moleculeS Trembleau, S Gregori, G Penna, et al.
Pageof 3